該当箇所へ

MorphoSys Digitalizes Large-Molecule R&D with Genedata Biologics

Ten years ago, when MorphoSys looked for a partner to help them digitalize their biopharma R&D, they quickly discovered that the systems designed for small molecules could not handle their specific large-molecule discovery requirements because the tasks and workflows are completely different. Then they found Genedata – a company who really understands the challenges of working with biotherapeutics. As an early adopter of the Genedata Biologics built for biologics platform,  MorphoSys increased efficiency and dramatically improved process quality right from the start. Since then, MorphoSys and Genedata have developed a close and collaborative relationship.


Two-minute video highlighting how Genedata's built for biologics platform transformed R&D at MorphoSys